Needham & Company
-
Inozyme Pharma to Participate at the 22nd Annual Needham Virtual Healthcare Conference
-
Inozyme Pharma to Present at the 21st Annual Needham Virtual Healthcare Conference
-
Inozyme Pharma (INZY) Reiterated at Buy by Needham & Company with $23 Price Target, INZ-701 Data is Encouraging and "Near Best-Case"
-
Needham & Company Reiterates Buy Rating on Inozyme Pharma Inc. (INZY)
-
UPDATE: Needham & Company Starts Inozyme Pharma Inc. (INZY) at Buy

